Gynae BT 2017

Results  3-year PFS 74.4% Vs 69% (p=0.029)  Median PFS- HR 0.68  Statistically significant improvement in median PFS Conclusion : Gemcitabine + cisplatin CRT followed by brachy & adjuvant gem/cis CT improved survival

outcomes with increased but clinically manageable toxicity compared to standard Rx

GUSTAVE ROUSSY

THÈME DU DIAPORAMA